Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Birophen (myrtle oil compound) spray plus nasal irrigation in children with allergic rhinitis
ChiCTR2100052863Phase 4Not yet recruiting
- Sponsor
- Children's Hospital, Zhejiang University School of Medicine
- Start
- Oct 2021
- Countries
- 1
01
Overview
Phase 4, open-label trial of Birophen in allergic rhinitis (AR) (4 arms), sponsored by Children's Hospital, Zhejiang University School of Medicine. Primary endpoint: Symptom score. Planned start Oct 2021; status: not yet recruiting.
02
Drugs
Birophen
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on ChiCTR2100052863.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100052863.